Genzyme

Genzyme Corporation is an American biotechnology company based in Cambridge, Massachusetts. It was founded in 1981 by Sheridan Snyder and George M. Whitesides. Genzyme is a subsidiary of Sanofi, a global pharmaceutical company. The company focuses on developing and delivering transformative therapies for patients affected by rare and debilitating diseases.

History

Genzyme was established in 1981 and initially focused on developing enzyme replacement therapies. The company's first major success came with the development of Ceredase, a treatment for Gaucher's disease. This was followed by the development of Cerezyme, an improved version of Ceredase.

In 2011, Genzyme was acquired by Sanofi for approximately $20.1 billion. The acquisition allowed Sanofi to expand its presence in the biotechnology sector and leverage Genzyme's expertise in rare diseases.

Products and Services

Genzyme's product portfolio includes treatments for a variety of rare diseases, including:

• Cerezyme - Enzyme replacement therapy for Gaucher's disease.
• Fabrazyme - Enzyme replacement therapy for Fabry disease.
• Myozyme - Enzyme replacement therapy for Pompe disease.
• Aldurazyme - Enzyme replacement therapy for Mucopolysaccharidosis I (MPS I).
• Lumizyme - Another enzyme replacement therapy for Pompe disease.

In addition to enzyme replacement therapies, Genzyme also develops treatments for multiple sclerosis, oncology, and other conditions.

Research and Development

Genzyme is known for its strong focus on research and development (R&D). The company invests heavily in R&D to discover and develop new therapies for rare and debilitating diseases. Genzyme's R&D efforts are supported by its state-of-the-art facilities and collaborations with academic institutions and other biotechnology companies.

Corporate Structure

Genzyme operates as a subsidiary of Sanofi and is integrated into Sanofi's global operations. The company maintains its headquarters in Cambridge, Massachusetts, and has additional facilities and offices around the world.

Corporate Social Responsibility

Genzyme is committed to corporate social responsibility (CSR) and sustainability. The company engages in various initiatives to support patients, communities, and the environment. These initiatives include patient assistance programs, community outreach, and efforts to reduce the environmental impact of its operations.

See Also

• Sanofi
• Biotechnology
• Enzyme replacement therapy
• Rare diseases

External Links

   This article is a medical stub. You can help WikiMD by expanding it!